Abstract
We investigated the beneficial effects of midazolam against vascular endothelial growth factor (VEGF)-induced vascular leakage and its molecular mechanism of action in human retinal endothelial cells (HRECs) and the retinas of diabetic mice. Midazolam inhibited VEGF-induced elevation of intracellular Ca2+, generation of reactive oxygen species (ROS), and transglutaminase activation in HRECs; these effects were reversed by the GABA, type A (GABAA) receptor antagonist flumazenil but not by the translocator protein antagonist PK11195. Midazolam also prevented VEGF-induced disassembly of adherens junctions and in vitro permeability. Intravitreal injection of midazolam prevented hyperglycemia-induced ROS generation, transglutaminase activation, and subsequent vascular leakage in the retinas of diabetic mice, and those effects were reversed by flumazenil. The roles of flumazenil were further supported by identifying GABAA receptors in mouse retinas. Thus, midazolam prevents hyperglycemia-induced vascular leakage by inhibiting VEGF-induced intracellular events in the retinas of diabetic mice.-Lee, Y.-J., Kim, M., Lee, J.-Y., Jung, S.-H., Jeon, H.-Y., Lee, S.-A., Kang, S., Han, E.-T., Park, W. S., Hong, S.-H., Kim, Y.-M., Ha, K.-S. The...Continue Reading
References
Jul 15, 1995·Lancet·T M BauerW E Haefeli
Jan 1, 1996·Archives of Ophthalmology·A P AdamisJ W Miller
Mar 30, 1999·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A F SteinlaufR J Groszmann
Dec 26, 2001·The Journal of Pharmacology and Experimental Therapeutics·H MöhlerU Rudolph
Aug 7, 2002·European Journal of Pharmacology·Liliana A MonasteroloM Mónica Elías
Dec 4, 2003·Diabetes/metabolism Research and Reviews·Ruth B CaldwellR William Caldwell
Jan 2, 2004·The New England Journal of Medicine·Robert N Frank
May 27, 2005·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·H-P Hammes
Jul 11, 2006·Trends in Pharmacological Sciences·Vassilios PapadopoulosMoshe Gavish
Oct 25, 2006·Nature Cell Biology·Julie Gavard, J Silvio Gutkind
Nov 17, 2007·European Journal of Anaesthesiology·K GhoriG D Shorten
Jan 5, 2008·Handbook of Experimental Pharmacology·K T Olkkola, J Ahonen
Jul 18, 2008·Anesthesia and Analgesia·Jan F A HendrickxSteven L Shafer
Sep 6, 2008·British Journal of Anaesthesia·G-C SunF-Z Shaw
Sep 20, 2008·Physical Therapy·W Todd Cade
Dec 24, 2008·Anesthesiology·Hee Kyoung JooByeong Hwa Jeon
Mar 20, 2010·Cardiovascular Research·Volker SpindlerJens Waschke
Feb 15, 2012·Ophthalmology·Quan Dong NguyenUNKNOWN RISE and RIDE Research Group
Aug 28, 2012·Diabetes·Mahendra Prasad BhattKwon-Soo Ha
Jan 11, 2013·Physiological Reviews·Josephine M Forbes, Mark E Cooper
Jul 26, 2013·Diabetes·Mahendra Prasad BhattKwon-Soo Ha
Oct 22, 2013·Cardiovascular Research·Young-Cheol LimKwon-Soo Ha
Mar 8, 2014·Science·R J Dwayne Miller
Apr 8, 2014·EMBO Molecular Medicine·Iacovos P MichaelAndras Nagy
Sep 23, 2014·Cardiovascular Research·Mahendra Prasad BhattKwon-Soo Ha
Jan 17, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Li LiuGuonian Wang
Jul 23, 2015·Ophthalmology·David M BrownJean-François Korobelnik
Oct 16, 2015·British Journal of Clinical Pharmacology·Marco L A Sivilotti
Nov 27, 2015·Molecules and Cells·Hee Kyoung JooByeong Hwa Jeon
Apr 14, 2016·Biochemistry·Fei LiShelagh Ferguson-Miller
May 22, 2016·Diabetes·Yeon-Ju LeeKwon-Soo Ha
Jul 2, 2016·Expert Opinion on Investigational Drugs·Michael Steven TolentinoMichael John Tolentino
Sep 13, 2016·International Journal of Molecular Sciences·Mark T Bolinger, David A Antonetti
Sep 15, 2016·World Journal of Diabetes·Michael W Stewart
Dec 14, 2016·Molecular Medicine Reports·Jing-Yu LiuJin-Shan Liu
Jun 28, 2017·Curēus·Badar HasanMaryam Hasan
Jul 29, 2017·The Journal of Endocrinology·Yeon-Ju LeeKwon-Soo Ha